Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-28 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Markowitz Wayne CIK: 0001991414 Role: Officer (CVP, JAPAC) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-28 | Code: M (Exercise of derivative) Shares: +9,628 | Price: $74.02 Total Value: $712,664.56 Shares Owned After: 31,307.8708 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-07-28 | Code: S (Open market sale) Shares: -9,628 | Price: $85.06 Total Value: $818,957.68 Shares Owned After: 21,679.8708 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Option (Right to Acquire) Date: 2026-07-28 | Code: M (Exercise of derivative) Shares: -9,628 | Price: $0.00 Exercisable: N/A | Expires: 2030-09-13 Shares Owned After: 9,628 | Ownership: D (Direct) --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-07-28)